Human Genetics Commission
This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (February 2011) |
The Human Genetics Commission (HGC) was an advisory non-departmental public body that advised the UK government on the ethical and social aspects of genetics. This included genetic testing, cloning and other aspects of molecular medicine. The Commission was created after a review of the UK government biotechnology advisory framework in 1999. It was chaired initially by the lawyer, Baroness Helena Kennedy QC and, from 2007 to 2009, the acting chair was Sir John Sulston. From 2009, the Commission was chaired by Professor Jonathan Montgomery and comprised 21 members whose backgrounds include the law, medicine, consumer affairs, philosophy and ethics, scientific research, and clinical practice. Representatives of the Chief Medical Officers of England, Scotland, Wales, and Northern Ireland also sat on the Commission.[1][2]
The Commission was abolished when quangos were reviewed by the newly elected government in October 2010. The Commission published its final paper in May 2012.[1][3][4]
References[]
- ^ a b "Human Genetics Commission". hgc.gov.uk. Archived from the original on 17 October 2011. Retrieved 10 December 2012.
- ^ "Support". Patient website. Retrieved 10 February 2014.
- ^ Jeeg (15 October 2010). "UK's Human Genetics Commission Abolished- Is the Public Interest Being Served?". councilforresponsiblegenetics.org. Retrieved 10 December 2012.
- ^ Dr Rebecca Hill (7 June 2012). "Human Genetics Commission publish final report". bionews.org.uk. Retrieved 10 December 2012.
External links[]
- Human Genetics Commission archived website (archived by the UK National Archives on 4 May 2012)
- Defunct non-departmental public bodies of the United Kingdom government
- Department of Health and Social Care
- Ethics commissions
- Genetics in the United Kingdom
- Genetics organizations
- Medical regulation in the United Kingdom
- Regulation of biotechnologies